DecisionPoint Financial
CORT icon

DecisionPoint Financial’s Corcept Therapeutics CORT Stock Holding History

DecisionPoint Financial’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.26K Hold
11
– – ﹤0.01% 484
2026
Q2 		$974 Hold
11
– – ﹤0.01% 453
2026
Q1 		$444 Hold
11
– – ﹤0.01% 504
2025
Q4 		$383 Hold
11
– – ﹤0.01% 589
2025
Q3 		$927 Hold
11
– – ﹤0.01% 345
2025
Q2 		$763 Buy
+11
New +$798 ﹤0.01% 363

Other funds holding CORT

KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Brown Capital Management
Brown Capital Management Baltimore, Maryland $527M AUM 33.67% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Stanley-Laman Group
Stanley-Laman Group Berwyn, Pennsylvania $915M AUM 50.26% 1-Year Est. Return
Amalgamated Bank
Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Linden Thomas Advisory Services
Linden Thomas Advisory Services Charlotte, North Carolina $1.26B AUM 37.95% 1-Year Est. Return

DecisionPoint Financial's CORT Position: Q3 2026 in Review

DecisionPoint Financial held its Corcept Therapeutics (CORT) position steady in Q3 2026 at 11 shares worth $1.26K. The position accounts for ﹤0.01% of the portfolio, ranked #484.

DecisionPoint Financial first reported a position in CORT in Q2 2025 and has held it in 6 quarters since. 123 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • DecisionPoint Financial held 11 shares of Corcept Therapeutics worth $1.26K as of Q3 2026.
  • DecisionPoint Financial left its Corcept Therapeutics share count unchanged in Q3 2026.
  • Corcept Therapeutics made up ﹤0.01% of DecisionPoint Financial's portfolio in Q3 2026, its #484 holding.
  • DecisionPoint Financial first reported a position in Corcept Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • 123 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on DecisionPoint Financial's 13F filing for Q3 2026, filed 27 Oct 2026.